Lv62
2220 积分 2024-07-01 加入
Heart failure with preserved ejection fraction therapeutics: in search of the pillars
24天前
已完结
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
24天前
已完结
Real-world challenges for guideline-directed medical therapy intolerance in heart failure: A single-center prospective cohort study
24天前
已完结
Contextualizing Risk Among Patients With Heart Failure
24天前
已完结
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum
24天前
已完结
Heart Failure with Preserved Ejection Fraction: A Review
24天前
已关闭
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
24天前
已完结
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
24天前
已完结
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
24天前
已完结
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
3个月前
已完结
皖公网安备34019202002308
